BALCHEM CORP
BALCHEM CORP
Aktie · US0576652004 · BCPC · 905650 (XNAS)
Übersicht
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
6
4
0
0
Kein Kurs
06.03.2026 06:27
Aktuelle Kurse von BALCHEM CORP
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XDQU: Quotrix
Quotrix
BCRSCB04.DUSD
EUR
06.03.2026 06:27
151,60 EUR
6,50 EUR
+4,48 %
XNAS: NASDAQ
NASDAQ
BCPC
USD
05.03.2026 21:00
175,70 USD
-6,96 USD
-3,81 %
IEXG: IEX
IEX
BCPC
USD
05.03.2026 20:58
176,05 USD
-6,61 USD
-3,62 %
XDUS: Düsseldorf
Düsseldorf
BCRSCB04.DUSB
EUR
05.03.2026 18:31
150,60 EUR
5,50 EUR
+3,79 %
XHAM: Hamburg
Hamburg
BCRSCB04.HAMB
EUR
05.03.2026 07:07
157,00 EUR
11,90 EUR
+8,20 %
XFRA: Frankfurt
Frankfurt
BL9B.F
EUR
27.02.2026 14:43
145,10 EUR
-
Free Float & Liquidität
Free Float 98,21 %
Shares Float 31,81 M
Ausstehende Aktien 32,39 M
Firmenprofil zu BALCHEM CORP Aktie
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
KI-Analyse von BALCHEM CORP
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu BALCHEM CORP
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name BALCHEM CORP
Firma Balchem Corporation
Symbol BCPC
Website https://www.balchem.com
Heimatbörse XNAS NASDAQ
WKN 905650
ISIN US0576652004
Wertpapierart Aktie
Sektor Basic Materials
Branche Chemicals - Specialty
CEO Theodore Lee Harris
Marktkapitalisierung 6 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 1,4 T
Adresse 52 Sunrise Park Road, 10958 Montvale
IPO Datum 1986-06-03
Dividenden von 'BALCHEM CORP'
Ex-Datum Dividende pro Aktie
23.12.2025 0,96 USD
26.12.2024 0,87 USD
26.12.2023 0,79 USD
28.12.2023 0,40 USD
23.12.2022 0,71 USD
27.12.2021 0,64 USD
24.12.2020 0,58 USD
27.12.2019 0,52 USD
24.12.2018 0,47 USD
26.12.2017 0,42 USD

Aktien-Splits

Datum Split
21.01.2010 3:2
22.01.2007 3:2
23.01.2006 3:2
21.01.2005 3:2
04.06.1998 3:2
04.10.1994 3:2
30.12.1991 4:3
31.12.1990 5:4

Kennungswechsel

Datum Von Zu
28.12.2006 BCP BCPC

Ticker Symbole

Name Symbol
Düsseldorf BCRSCB04.DUSB
Frankfurt BL9B.F
Hamburg BCRSCB04.HAMB
NASDAQ BCPC
Quotrix BCRSCB04.DUSD
Weitere Aktien
Investoren, die BALCHEM CORP halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
ASHTEAD CAPITAL INC 2ND PTY SNR SEC NTS 01/08/26 (REG S)
ASHTEAD CAPITAL INC 2ND PTY SNR SEC NTS 01/08/26 (REG S) Anleihe
AUTODESK INC
AUTODESK INC Aktie
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Aktie
BROADCO INC
BROADCO INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
FASTENAL CO
FASTENAL CO Aktie
HERMES INTERNATIONAL
HERMES INTERNATIONAL Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
RESMED CUFS/10
RESMED CUFS/10 Aktie
ROCHE FIN.EUROPE 16/23MTN
ROCHE FIN.EUROPE 16/23MTN Anleihe
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026